nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—SLC22A1—Metformin—polycystic ovary syndrome	0.915	1	CbGbCtD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000406	0.00478	CbGpPWpGaD
Rocuronium—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.000402	0.00473	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—DLG4—polycystic ovary syndrome	0.000401	0.00472	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.000397	0.00468	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000396	0.00466	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.000386	0.00455	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—FGF18—polycystic ovary syndrome	0.00038	0.00447	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000377	0.00444	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000377	0.00444	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.000375	0.00441	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.000375	0.00441	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000358	0.00422	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.000351	0.00413	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.00035	0.00413	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.000342	0.00403	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00034	0.00401	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.000331	0.0039	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00032	0.00377	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000316	0.00372	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000315	0.00371	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000299	0.00352	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000293	0.00345	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000289	0.00341	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000286	0.00336	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000285	0.00336	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000285	0.00336	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000282	0.00332	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000274	0.00323	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000272	0.0032	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000271	0.00319	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.000268	0.00316	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000267	0.00314	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000262	0.00308	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000259	0.00305	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000259	0.00304	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000252	0.00297	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000252	0.00296	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000251	0.00295	CbGpPWpGaD
Rocuronium—SLCO1A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00025	0.00295	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000249	0.00293	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000243	0.00286	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000242	0.00285	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000241	0.00284	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000241	0.00283	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000239	0.00281	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.000236	0.00278	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000233	0.00275	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000232	0.00273	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00023	0.00271	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00023	0.00271	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000221	0.00261	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000219	0.00258	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000216	0.00255	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000213	0.00251	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000212	0.0025	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000212	0.0025	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00021	0.00247	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000209	0.00246	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000208	0.00245	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000197	0.00232	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000193	0.00228	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000193	0.00228	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000193	0.00227	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000191	0.00225	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000186	0.00219	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—DLG4—polycystic ovary syndrome	0.000184	0.00217	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000184	0.00217	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000183	0.00215	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000182	0.00214	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00018	0.00212	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000178	0.00209	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000175	0.00207	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000175	0.00206	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000171	0.00201	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000171	0.00201	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000171	0.00201	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00017	0.00201	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00017	0.002	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000168	0.00198	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000168	0.00198	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000167	0.00197	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000162	0.00191	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000161	0.0019	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000161	0.0019	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000161	0.0019	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000159	0.00187	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000159	0.00187	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000158	0.00186	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000155	0.00183	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SUOX—polycystic ovary syndrome	0.000155	0.00183	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000152	0.00179	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.000152	0.00179	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000151	0.00178	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000149	0.00176	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000146	0.00172	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000146	0.00172	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000146	0.00172	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000144	0.0017	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000142	0.00168	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000141	0.00166	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000139	0.00164	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000137	0.00161	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000133	0.00157	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000133	0.00157	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00013	0.00154	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00013	0.00153	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000129	0.00152	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—STAR—polycystic ovary syndrome	0.000127	0.0015	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000127	0.0015	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000126	0.00148	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TEAD2—polycystic ovary syndrome	0.000123	0.00144	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000123	0.00144	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00012	0.00141	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000119	0.0014	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000118	0.00139	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000118	0.00139	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000113	0.00133	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000109	0.00129	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000108	0.00127	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000108	0.00127	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000107	0.00126	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000107	0.00126	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000107	0.00126	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000104	0.00122	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000104	0.00122	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000103	0.00121	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000103	0.00121	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000102	0.00121	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000102	0.0012	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000101	0.00119	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.0001	0.00118	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	9.93e-05	0.00117	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—LHB—polycystic ovary syndrome	9.86e-05	0.00116	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	9.8e-05	0.00115	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SRD5A1—polycystic ovary syndrome	9.74e-05	0.00115	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HSD3B2—polycystic ovary syndrome	9.64e-05	0.00113	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.62e-05	0.00113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.44e-05	0.00111	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.37e-05	0.0011	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKR1C1—polycystic ovary syndrome	9.33e-05	0.0011	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	9.32e-05	0.0011	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—STAR—polycystic ovary syndrome	9.29e-05	0.00109	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	9.28e-05	0.00109	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	9.21e-05	0.00108	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	9.18e-05	0.00108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	9.11e-05	0.00107	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	8.93e-05	0.00105	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	8.74e-05	0.00103	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.65e-05	0.00102	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.65e-05	0.00102	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SULT2A1—polycystic ovary syndrome	8.59e-05	0.00101	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.34e-05	0.000982	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—RRM2—polycystic ovary syndrome	8.32e-05	0.00098	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	8.28e-05	0.000975	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	8.14e-05	0.000959	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	8.09e-05	0.000953	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—YAP1—polycystic ovary syndrome	8.02e-05	0.000944	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	7.9e-05	0.00093	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.86e-05	0.000925	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.79e-05	0.000918	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NAMPT—polycystic ovary syndrome	7.7e-05	0.000907	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.66e-05	0.000902	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.64e-05	0.0009	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP11A1—polycystic ovary syndrome	7.61e-05	0.000896	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.55e-05	0.00089	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	7.45e-05	0.000877	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	7.2e-05	0.000848	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.19e-05	0.000846	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP17A1—polycystic ovary syndrome	7.07e-05	0.000833	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	7.04e-05	0.000829	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.95e-05	0.000819	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	6.82e-05	0.000803	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.78e-05	0.000798	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	6.33e-05	0.000746	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	6.27e-05	0.000739	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	6.2e-05	0.00073	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	6.18e-05	0.000727	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.16e-05	0.000725	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TH—polycystic ovary syndrome	6.12e-05	0.000721	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	6.08e-05	0.000715	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5.95e-05	0.000701	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.95e-05	0.000701	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	5.86e-05	0.00069	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.79e-05	0.000682	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	5.64e-05	0.000665	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	5.63e-05	0.000663	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.61e-05	0.000661	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP19A1—polycystic ovary syndrome	5.6e-05	0.000659	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.57e-05	0.000656	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	5.56e-05	0.000654	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	5.51e-05	0.000649	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.38e-05	0.000634	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	5.25e-05	0.000618	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.21e-05	0.000614	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.2e-05	0.000613	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	5.17e-05	0.000608	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	5.16e-05	0.000608	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	5.1e-05	0.0006	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	5e-05	0.000588	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.92e-05	0.00058	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.84e-05	0.00057	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.8e-05	0.000565	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.76e-05	0.00056	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.73e-05	0.000556	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.51e-05	0.000531	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	4.48e-05	0.000528	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TH—polycystic ovary syndrome	4.47e-05	0.000526	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	4.42e-05	0.00052	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	4.35e-05	0.000512	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	4.22e-05	0.000497	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.21e-05	0.000495	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	4.09e-05	0.000481	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.01e-05	0.000473	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.95e-05	0.000465	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	3.91e-05	0.000461	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	3.65e-05	0.00043	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.64e-05	0.000428	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.64e-05	0.000428	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.5e-05	0.000413	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	3.48e-05	0.000409	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.47e-05	0.000409	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	3.41e-05	0.000402	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.38e-05	0.000398	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.37e-05	0.000397	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	3.36e-05	0.000396	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	3.35e-05	0.000394	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	3.3e-05	0.000388	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	3.2e-05	0.000377	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	3.18e-05	0.000375	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	3.17e-05	0.000374	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	3.07e-05	0.000362	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.06e-05	0.00036	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.01e-05	0.000354	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.79e-05	0.000329	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.66e-05	0.000313	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.61e-05	0.000307	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	2.49e-05	0.000293	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	2.46e-05	0.000289	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—INS—polycystic ovary syndrome	2.44e-05	0.000288	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.24e-05	0.000263	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	2.19e-05	0.000258	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.95e-05	0.00023	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	1.88e-05	0.000221	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	1.87e-05	0.00022	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.81e-05	0.000213	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.81e-05	0.000213	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.72e-05	0.000202	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.38e-05	0.000163	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.18e-05	0.000139	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	8.17e-06	9.62e-05	CbGpPWpGaD
